Clarus Therapeutics Revenue and Competitors

Chicago, IL USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Clarus Therapeutics's estimated annual revenue is currently $4.2M per year.(i)
  • Clarus Therapeutics's estimated revenue per employee is $201,000

Employee Data

  • Clarus Therapeutics has 21 Employees.(i)
  • Clarus Therapeutics grew their employee count by 0% last year.

Clarus Therapeutics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15.9M7930%N/AN/A
#2
$91.5M4557%N/AN/A
#3
$26.1M13025%$35MN/A
#4
$15.3M76-4%N/AN/A
#5
$6.6M33-25%N/AN/A
#6
$5.6M28-7%N/AN/A
#7
$4.2M21-36%N/AN/A
#8
$10.1M50-25%N/AN/A
#9
$225.5M112219%N/AN/A
#10
$3.2M16-27%N/AN/A
Add Company

What Is Clarus Therapeutics?

Clarus Therapeutics, Inc. is a men's specialty pharmaceutical company with a mission to help men with hypogonadism, a condition associated with a deficiency or absence of endogenous testosterone. We are working hard every day to make a difference in the lives of affected men. As a privately-held company, Clarus Therapeutics is backed by Thomas, McNerney & Partners, L.P., H.I.G. BioHealth Partners, ProQuest Investments, C-Bridge Capital Partners, LLC, BVCF Management, Ltd. and Pavilion Capital Pte Ltd. To learn more, visit clarustherapeutics.com. View our community guidelines: http://bit.ly/2H9QmH5

keywords:N/A

N/A

Total Funding

21

Number of Employees

$4.2M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Clarus Therapeutics News

2022-04-20 - Clarus Therapeutics announces patent notice

NORTHBROOK -- Clarus Therapeutics Holdings, Inc., recently announced that it has received a notice of allowance from the United States...

2022-04-19 - Clarus Therapeutics Announces Notice of Allowance for ...

Clarus Therapeutics Announces Notice of Allowance for Patent Claims Covering JATENZO® (testosterone undecanoate). Published: Apr 28, 2022.

2022-04-17 - Clarus Therapeutics Announces Pricing of Upsized $30.0 ...

Clarus Therapeutics Holdings, Inc. is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women –...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.6M210%N/A
#2
$3.1M225%N/A
#3
$3.4M23-8%N/A
#4
$4.9M2414%N/A
#5
$4.4M250%N/A